Legend Biotech Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-198.5M | $-240.7M | $42.2M | $20.2M |
| FY2022 | $-201.3M | $-222.2M | $20.9M | $34.3M |
| FY2023 | $-393.3M | $-413.4M | $20.1M | $47.7M |
| FY2024 | $-144.0M | $-158.1M | $14.1M | $68.9M |
| FY2025 | $-100.2M | $-128.8M | $28.6M | $64.6M |